biostudies-literatureUnknown7(2)Yu H<h4>What is already known about this topic?</h4>Human immunodeficiency virus (HIV) low-level viremia (LLV) during antiretroviral therapy (ART) occurs frequently in Dehong Dai and Jingpo Autonomous Prefecture, Yunnan Province.<h4>What is added by this report?</h4>Among people living with HIV who achieved virological success [viral load (VL) <1,000 copies/mL] after initiating ART in Dehong Prefecture, Southwest China, 17.6% experienced first-year LLV of 50-999 copies/mL First-year LLV emerged as an independent risk factor for subsequent viral non-suppression compared with participants maintaining first-year VL <50 copies/mL.<h4>What are the implications for public health practice?</h4>Enhanced monitoring and interventions for early LLV occurrence during the first year of ART are essential, iChina CDC weekly45-52https://www.ebi.ac.uk/biostudies/studies/S-EPMC11754852biostudies-literatureAssociations of First-Year Low-Level Viremia with Subsequent Viral Non-Suppression in People Living with HIV on Antiretroviral Therapy - Dehong Dai and Jingpo Autonomous Prefecture, Yunnan Province, China, 2008-2021.PMC11754852Feng YCao DLi PYu HShi YYang YJin CYe RCao YXiao GDuan SWei HSun JfalseAssociations of First-Year Low-Level Viremia with Subsequent Viral Non-Suppression in People Living with HIV on Antiretroviral Therapy - Dehong Dai and Jingpo Autonomous Prefecture, Yunnan Province, China, 2008-2021.<h4>What is already known about this topic?</h4>Human immunodeficiency virus (HIV) low-level viremia (LLV) during antiretroviral therapy (ART) occurs frequently in Dehong Dai and Jingpo Autonomous Prefecture, Yunnan Province.<h4>What is added by this report?</h4>Among people living with HIV who achieved virological success [viral load (VL) <1,000 copies/mL] after initiating ART in Dehong Prefecture, Southwest China, 17.6% experienced first-year LLV of 50-999 copies/mL First-year LLV emerged as an independent risk factor for subsequent viral non-suppression compared with participants maintaining first-year VL <50 copies/mL.<h4>What are the implications for public health practice?</h4>Enhanced monitoring and interventions for early LLV occurrence during the first year of ART are essential, i2025-01-01T00:00:00Z2025 Jan2025-04-05T10:18:21.07Z2025-04-05T10:18:21.07ZS-EPMC117548523986628810.46234/ccdcw2025.010